Hauptforum Forum: Community User: Hansmuller
GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it will report third quarter 2023 financial results on Wednesday, November 8, 2023, after the close of U.S. markets. Following the release, management will host a live conference call and webcast, including Q&A, at 4:30 p.m. ET to provide a corporate update and discuss financial results.
Geovax Labs Inc NASDAQ 0.52 -0.01 (-1.46%) Nov 6, 2023, 12:36:21 PM EST SHARE PRICE Day's RangeN/A - N/A52 Week Range0.47 - 1.39Pharmaceutical Preparatio... Are you a Financial Writer? Become a Fintel Contributor Today Short Interest shares - source: NASDAQShort Interest Ratio8.11 Days to CoverShort Interest % Float2.83% - source: NASDAQ (short interest), Capital IQ (float) Off-Exchange Short Volume9,349 shares - source: FINRA (inc. Dark Pool volume)Off-Exchange Short Volume Ratio41.75 % - source: FINRA (inc. Dark Pool volume)
|
|
Thema | ||
|---|---|---|---|
| 1 | Quantum Emotion, redefrei | +2,02 % | |
| 2 | Security der nächsten Generation | +2,02 % | |
| 3 | VONOVIA Hauptdiskussion | +0,15 % | |
| 4 | NEL ASA Hauptdiskussion | +1,55 % | |
| 5 | TUI Hauptforum | +0,91 % | |
| 6 | BTC/USD Hauptdiskussion | +0,21 % | |
| 7 | NIKE Hauptdiskussion | -2,76 % | |
| 8 | ATOS Hauptdiskussion | -0,24 % | |
| 9 | Desert Control Hauptdiskussion | ±0,00 % | |
| 10 | MODERNA INC. DL-,0001 Hauptdiskussion | +13,86 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Quantum Emotion, redefrei | +2,02 % | |
| 2 | Security der nächsten Generation | +2,02 % | |
| 3 | VONOVIA Hauptdiskussion | +0,15 % | |
| 4 | NEL ASA Hauptdiskussion | +1,55 % | |
| 5 | TUI Hauptforum | +0,91 % | |
| 6 | NIKE Hauptdiskussion | -2,76 % | |
| 7 | ATOS Hauptdiskussion | -0,24 % | |
| 8 | Desert Control Hauptdiskussion | ±0,00 % | |
| 9 | MODERNA INC. DL-,0001 Hauptdiskussion | +13,86 % | |
| 10 | Linien und Wellen Austausch Forum | +3,79 % | Alle Diskussionen |